# Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/treatment-characteristics-and-real-world-progression-free-survival-in-patients/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Nicolas Girard,Jair Bar,Pilar Garrido,Marina Chiara Garassino,Fiona McDonald,F. Mornex,Andrea Riccardo Filippi,Hans J.M. Smit,Solange Peters,John K. Field,Daniel C. Christoph,Anne Sibille,Rainer Fietkau,Vilde Drageset Haakensen,C. Chouaïd,Ben Markman,T. Jeroen N. Hiltermann,Álvaro Taus,W. Sawyer,A. Allen,Pratibha Chander,Muriel Licour,Benjamin Solomon |
| Citations | 231 |
| DOI | 10.1016/j.jtho.2022.10.003 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.jto.org/article/S1556086422018536/pdf |
| OpenAlex ID | https://openalex.org/W4307584521 |
| PMID | 36307040 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Nicolas Girard](https://scholariq.org/researchers/nicolas-girard/)
- [Jair Bar](https://scholariq.org/researchers/jair-bar/)
- [Marina Chiara Garassino](https://scholariq.org/researchers/marina-chiara-garassino/)
- [Benjamin Solomon](https://scholariq.org/researchers/benjamin-solomon/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
